Brexogen Inc. was founded in March 2019 with the goal of developing the first exosome therapeutics for incurable diseases. Our goal is being achieved by launching various pipelines. Through these steps, we are taking one step closer to developing exosome therapeutics. Brexogen's technology will continue to grow together with the well-being of patients. Our team will do our best to continuously lead exosome industry.